Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

Rami Apelian and Marija Geertsen Share Insights from 9 Poster Presentations on Migraine Prevention & Treatment at AHS 2022
Rami Apelian and Marija Geertsen Share Insights from 9 Poster Presentations on Migraine Prevention & Treatment at AHS 2022
Shots: Rami spoke about study design of the P-III study evaluating its lead candidate in migraine Marija Geertsen talked about different treatment options available for migraine & neurological diseases The interview highlights the development plans and global expansion of various therapies for brain diseases Smriti: Explain the details (MOA, ROA, formulations, etc.) of Vyepti. Rami Apelian: VYEPTI®…
August 29, 2022
Jeremiah Robison, Founder, and CEO of Cionic Shares Insights on the Collaboration with Yves Behar’s fuseproject for the Cionic Neural Sleeve
Jeremiah Robison, Founder, and CEO of Cionic Shares Insights on the Collaboration with Yves Behar’s fuseproject for the Cionic Neural Sleeve
Shots: Jeremiah spoke about Cionic’s recent collaboration with designer Yves Behar and his design firm, fuseproject to deliver its bionic leg wearable to determine human mobility in real-time He talked about the results from the CIONIC trial and also discussed home usability trials to understand the impact of the Neural Sleeve on mobility over time…
August 24, 2022
Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022
Dr. Vivek Lal, Founder & CEO at ResBiotic Shares Insights from the New Preclinical Data for resB Lung Support Presented at DDW 2022
Shots: Dr. Vivek talked about the results from the preclinical study of its probiotic and herbal supplement for lung health in a poster presented at DDW 2022 He also spoke about how resB helps to decrease MMP-9 inflammatory pathway activity, associated with tissue damage and neutrophilic inflammation The interview provides a deep understanding of Resbiotic’s…
August 23, 2022
Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia
Laura Yecies, CEO at Bone Health Technologies Shares Insights on Osteoporosis Prevention Study for Postmenopausal Women With Osteopenia
Shots: Laura spoke about the non-drug intervention study to treat osteopenia in postmenopausal women She also talked about the company’s OsteoBoost technology which is a convenient treatment to improve bone density The interview provides an understanding of the company’s vision to develop new treatment options for osteoporosis and osteopenia Smriti: Brief us about the background behind…
August 17, 2022
Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
Shots: Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes) He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detail The interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes care Smriti: Tell us how Lilly is leading…
August 16, 2022
PharmaShots Interview Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
Shots:  Laurent spoke about the study design of its nanoparticle therapy to enhance the cancer-killing effect of radiation, which was presented at ASCO 2022 Laurent also highlighted how this nanoparticle therapy can be a potential radio enhancer in various tumor types and across lines of therapy The interview summarizes Nanobiotix’s vision to advance nanoparticles across…
August 10, 2022
PharmaShots Interview Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
Shots:  Purnanand spoke about the preclinical results of lead candidate in oncology and how its identifies IL-38 as a target to treat cancer Purnanand also talked about Immunome’s collaboration with Fox Chase Cancer Center for the further development of its prime product The interview gives a understanding of Immunome’s goal of developing therapeutics to treat…
August 2, 2022
PharmaShots Interview Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia
PharmaShots Interview: Abdul Mullick, CEO at Kyowa Kirin Shares Insights on the Launch of a Virtual Exhibition to Highlight Issues of Rare Disease, X-linked Hypophosphataemia
Shots: Abdul spoke about the launch of a digital exhibition ‘Shine a light’ to raise awareness about rare diseases Abdul also emphasized the significance of this awareness campaign for the patients who were unaware of X-linked Hypophosphataemia(XLH) The interview provides a profound understanding of Kyowa Kirin's initiatives to help patients suffering from XLH Smriti: Can we…
July 27, 2022
Load more